Donepezil Treatment of Hypersomnia After COVID-19
The long-term effects of coronavirus disease-2019 (COVID-19) are not yet fully understood and some are due to central nervous system involvement. COVID-19 was reported to cause fatigue in some people after a long-term viral illness, characterized by daytime wakefulness and disturbed sleep cycles. He...
Main Authors: | Demet Aygün Üstel, Pervin İşeri, Meltem Can İke |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Yayinevi
2021-12-01
|
Series: | Türk Nöroloji Dergisi |
Subjects: | |
Online Access: | https://tjn.org.tr/jvi.aspx?pdir=tjn&plng=eng&un=TJN-29726&look4= |
Similar Items
-
Drug-induced hypersomnia
by: T. M. Ostroumova, et al.
Published: (2021-04-01) -
Post-COVID central hypersomnia, a treatable trait in long COVID: 4 case reports
by: Clémence Morelli-Zaher, et al.
Published: (2024-02-01) -
COVID-19 Vaccine Could Trigger the Relapse of Secondary Hypersomnia
by: Wu M, et al.
Published: (2021-12-01) -
Challenges in Diagnosing Narcolepsy and Idiopathic Hypersomnia
by: Seung-Chul Hong, et al.
Published: (2023-03-01) -
Central hypersomnia and chronic insomnia: expanding the spectrum of sleep disorders in long COVID syndrome - a prospective cohort study
by: Alissa Elen Formiga Moura, et al.
Published: (2022-11-01)